Amarin Corp Plc (AMRN)

[sts66]

If TDA watches binary events and tries to lower their risk in advance by raising margin to 100%, then they should have done it prior to the ANCHOR Adcom, before *any* biotech Adcom, and before P3 or P4 results are released when it's known that their release is imminent - so has anyone see TDA do this before for any biotech? I can't imagine TDA "targeting" only AMRN like this.

Hard for me to believe enough people own AMRN on margin that outweighs the total value of other investments in their account that TDA has a major financial risk if R-IT has negative results - I mean if you can't meet the margin call they can sell whatever else you own in your account to cover the losses.